About Loyal
Loyal is a clinical-stage veterinary medicine company developing longevity drugs for dogs. Our mission is to help dogs live longer, healthier lives.
We're pioneering a new category of veterinary prescription drugs that proactively and preventatively target the underlying drivers of aging, delaying the onset of disease and preserving quality of life as dogs age. We've already made significant progress in our mission to develop the first FDA-approved drugs to extend canine lifespan: as of early 2026 we've completed two of three major FDA review sections for our lead program, LOY-002, and are targeting submission of the third and final section later this year.
Loyal is a well-funded startup with teams of scientists, veterinarians, engineers, operators, and creatives. You'll help us continue on our path of earning FDA approval for the first lifespan extension medicine for any species, and change what's possible for the dogs we love.
About the role
The Director of CMC Quality Assurance will build and lead Loyal's CMC QA function, owning the quality systems, CDMO oversight, and PAI readiness that underpin our path to FDA approval and commercial launch. Reporting to the VP of Quality Assurance, this is a hands-on leadership role responsible for building what doesn't yet exist, not maintaining inherited infrastructure in a lean, fast-moving startup environment.
This person will work closely with CMC, Regulatory Affairs, and Supply Chain, and will serve as the primary QA voice on CMC program decisions, technical transfers, and regulatory submissions.
Your daily work will include
- Build, own, and continuously improve Loyal's CMC quality management system: SOPs, document control, change control, deviation management, CAPA, and risk management processes; ensure systems are fit for purpose now and scalable through commercial launch
- Serve as the primary QA point of contact for CDMOs, contract testing laboratories, and key raw material and excipient suppliers, lead qualification, audit execution, and ongoing quality oversight of all external partners
- Negotiate, draft, and maintain quality agreements with CDMOs and contract testing laboratories; drive timely execution and hold partners accountable to commitments
- Plan and conduct routine GMP audits of CDMOs and suppliers; own audit finding responses and track CAPAs to closure
- Lead batch disposition decisions for clinical and development batches; ensure complete, audit-ready documentation packages and timely release
- Review and approve analytical method validation protocols and reports, stability protocols and data, executed batch records, CoAs, and CoCs
- Oversee deviation and OOS management originating from external partners through to closure
- Execute PAI readiness activities including quality systems documentation, validation packages, and site readiness; serve as QA lead during FDA inspections and agency interactions related to CMC
- Partner with Regulatory Affairs and CMC teams to ensure quality considerations are incorporated into program decisions, technical transfers, and filing activities; support QA input into NDA and other regulatory submissions
- Provide QA oversight of all tech transfer activities — site qualification, process comparability, transfer protocols, and batch record development
- Own the Annual Product Review (APR/PQR) process and QA sign-off on labeling for clinical and commercial supply
- Define, track, and report CMC QA KPIs: CDMO performance, CAPA cycle times, deviation trends, audit findings, quality agreement status, and batch disposition timelines; use metrics to drive external partner accountability and surface risks proactively to leadership
- Apply formal quality risk management principles (ICH Q9) across manufacturing and development activities
- Build quality infrastructure that supports the transition from clinical to commercial supply, including commercial batch release processes, post-approval change management, and commercial QMS requirements
- Balance compliance requirements with the practical realities of a fast-moving startup environment
About you
- BS., M.S., or Ph.D. in Pharmaceutical Sciences, Chemistry, Biology, or a related life science discipline; advanced degree strongly preferred
- 15+ years of pharmaceutical or biotechnology industry experience in quality assurance, with a significant portion in senior or lead CMC QA roles
- Has built CMC quality systems from the ground up — not just maintained inherited infrastructure — from development stage through NDA/BLA filing and approval
- Has directly managed CDMOs and contract testing labs from a QA perspective: qualification, auditing, quality agreements, batch record review, deviation and CAPA management
- Authored and owns SOPs, not just reviewed them
- Deep working knowledge of FDA GMP regulations (21 CFR Parts 210/211), ICH and VICH guidelines, and quality risk management principles
- Has led or co-led PAI preparation and been present during FDA inspections
- Experience supporting commercial batch release and post-approval change management
- Small molecule OSD experience required
- Comfortable operating without a large QA infrastructure — builds what's needed, prioritizes well, and doesn't wait for perfect conditions
- Strong written communication — produces clear, audit-ready documentation
- Veterinary or animal health industry experience preferred but not required
- Prior experience at a company navigating a Complete Response Letter, NDA resubmission, or first approval preferred but not required
Salary Range: $155,000 - $205,000
Loyal benefits
- Full-coverage health insurance — medical, dental and vision — for you and your dependents
- $1,000 home office equipment stipend
- $1,200/year learning budget for books, courses, etc.
- $250/month wellness budget for gym, cleaners, spa, food, etc.
- All 3-day weekends are turned into 4-day weekends 🎉
- Unlimited vacation and paid holidays
- Paw-ternity leave — adopt a dog and get a day off with your new family member 🐶
- Competitive salary
- Company equity options grant for new hires
Loyal is founded and led by a first-gen female CEO and is proud to be an equal opportunity employer. We do not discriminate against applicants based on gender, race or color, ethnicity or national origin, age, disability, religion, sexual orientation, gender identity or expression, veteran status, or any other applicable characteristics protected by law.
Our values
Moonshots, derisked methodically
Bringing the first longevity drug to market is an extremely difficult technical and social pursuit. To achieve this we must take bigger bets than the field has historically made, paired with the technical rigor to de-risk them step by step. We plan on both short and extremely long timescales, and we have the conviction to see our vision through to success or failure.
Opportunity is at the intersection
We lean into combining disciplines, expertise, and perspectives not normally adjacent. We design our organization to facilitate cross-pollination and cross-collaboration. We reject silos.
Expertise without ego
Titles do not determine who has a voice. We push back on each other, ask questions instead of issuing orders, and try to prove ourselves wrong. We are emotionally attached to the outcome, not our personal hypotheses, and welcome being challenged instead of treating it as a threat.
High agency, high humility
Most of what we're doing has never been done before, so we can't rely on established precedents to guide our way. We move forward to generate clarity, build strategies resilient to the fact that we don't know what we don't know, and design small experiments where we can fail safely, without jeopardizing the bigger mission.
Lead with transparency and context
We proactively and consistently share the why behind our strategy - not just the what - because we believe sharing context enables great people to make great decisions.
Empathy and respect for all life
Our patients are not just numbers. We deeply respect the value of every life, large and small and take our ethical responsibility to the families we treat extremely seriously.
